Earticle

초록

영어

The objective of this study was to investigate drug classification system in Korea and other developed countries. Laws and regulations of Korea regarding the system were retrieved from sources posted in Ministry of Government Legislation. We also reviewed previous research reports performed as part of government’s effort to reform the system The system in the foreign countries was retrieved from the official homepage operated by each country’s government. There have been two research funded by Korean government, which strongly suggested that the system should be reformed. However, we found that the system was never reformed and still effective. Drug classification system in US and most western countries consists of two categories, i.e., prescription drugs and non-prescription drugs except UK, which classifies into three categories: Prescription Only Medicines, Pharmacy Medicines, and General Sales List Medicines. Interestingly, in Japan, non-prescription drugs are further classified into three groups: Group 1, 2, and 3. Recently, Ministry of Health and Welfare (MOHW) in Korea proposed a plan to reclassify all the approved drugs according to purportedly rational and scientific criteria. However, the plan does not include reform of the existing laws and regulations, which appears that it is just one-time action rather than a sustainable administration backed up by law. Therefore, it is recommended that Korean MOHW take appropriate action on laws and regulations with regard to the system to meet global harmonization standard.

목차

Abstract
 연구 방법
  국내 의약품 분류체계 검토
  의약선진국의 의약품 분류체계 및 분류기준 검토
 연구결과
  국내 의약품 분류체계
  의약선진국의 의약품 분류체계 및 분류기준
 고찰
 결론
 감사의 말씀
 참고문헌

키워드

저자

• 손성호 [ Sung-Ho Sohn | 칠곡경북대학교병원 약제부 ]
• 유봉규 [ Bong Kyu Yoo | 가천대학교 약학대학 ] Correspondence to

참고문헌

발행기관

간행물

표지보기 관심저널 등록

• 간행물명

  한국임상약학회지 [Korean Journal of Clinical Pharmacy]

• 간기

  계간

• pISSN

  1226-6051

• 수록기간

  1991~2026

• 등재여부

  KCI 등재

• 십진분류

  KDC 518 DDC 615